Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DC-U4106 is a USP8-targeted inhibitor (Kd: 4.7 μM, IC50: 1.2 μM). DC-U4106 can use the ubiquitination pathway to promote the degradation of Erα. DC-U4106 inhibits the growth of tumor cells with low toxicity and can be used to study breast cancer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 2,140.00 | |
50 mg | 10-14 weeks | $ 2,785.00 | |
100 mg | 10-14 weeks | $ 3,520.00 |
Description | DC-U4106 is a USP8-targeted inhibitor (Kd: 4.7 μM, IC50: 1.2 μM). DC-U4106 can use the ubiquitination pathway to promote the degradation of Erα. DC-U4106 inhibits the growth of tumor cells with low toxicity and can be used to study breast cancer. |
Molecular Weight | 525.56 |
Formula | C29H27N5O5 |
CAS No. | 2410534-62-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
DC-U4106 2410534-62-0 inhibitor inhibit